investment highlights
We invest in health technology companies, both public and private.*
Example investments are shown below.
Example investments are shown below.
Last Updated ⇾ January 29, 2024
Investment in this commercial-stage medical technology company focused on patients who suffer from psychiatric disorders. Its commercial product, the NeuroStar® Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS.
See more: www.neuronetics.com
Executive Chairman and investor in this digital health platform for people with epilepsy company founded by two Johns Hopkins epileptologists.
See more: www.epiwatch.com
Initial investor and Board member in this diabetic foot wound therapy company. Sold to Derma Sciences, now part of Integra LifeSciences (NASDAQ: (IART).
Investment in this innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies.
See more: www.venusconcept.com
Prior member of Board of Directors and current investment in this leading provider of cancer screening and diagnostic tests, including Cologuard and Oncotype DX.
See more: www.exactsciences.com
Investment in this company which designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training.
See more: www.dynatronics.com
Founder, Executive Chairman, and investor in this advisory business comprised of world class experts in federal medicine who partner with promising life science ventures to develop and execute comprehensive strategies to work with the government, including advocacy and awareness programs for federal research or acquisition and securing U.S. and international regulatory approvals and certifications.
See more: www.HICatalysts.com
Investment in this first of its kind healthcare delivery model that integrates human intervention, tech intervention, clinical care and prevention to shift from a sick care system to a health focused delivery system.
*We are not currently seeking capital from outside investors to invest their funds. Vital Tech Partners, LLC investments include those personally from Michael Singer and Cowboys Capital LLC.
The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.
All opinions expressed on this website are solely the opinions of Vital Tech Partners, LLC (VTP). You should not treat any opinion or publicly-traded equity investment expressed by VTP as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of VTPs opinion. VTP’s opinions are based upon information it considers reliable, but VTP does not warrant its completeness or accuracy, and it should not be relied upon as such. VTP is not under any obligation to update or correct any information provided on this website and is subject to change without notice.
Publicly-traded equity investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives, financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. Past performance of publicly-traded equities is not indicative of future results. VTP does not guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment shown on this website. Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested.